Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Health Highlights: April 9, 2021
Prince Philip Dies At Age 99 Prince Philip, husband of Queen Elizabeth II, died Friday at Windsor Castle in England at age 99, Buckingham Palace...
Guys, Take the Lead in Self-Checks for Testicular Cancer
SUNDAY, April 11, 2021 -- Young men should become familiar with symptoms of testicular cancer and know how to do self-exams, an expert says. Though testicular...
Re-focusing on Getting Fit? Heart Experts Offer These Tips
SATURDAY, April 10, 2021 -- Want to get rid of all that weight you put on during the pandemic? To help out, the American Heart Association (AHA) is launching...
Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 5 to 9,...
AHA News: Not Just Bad Shoes and Sore Muscles – She Had Peripheral Artery Disease
FRIDAY, April 9, 2021 (American Heart Association News) -- Abigail Dudek celebrated her 40th birthday in Las Vegas a few months ago, grateful to go hiking and...
In-Hospital SARS-CoV-2 Mortality Declined Throughout Pandemic
FRIDAY, April 9, 2021 -- In-hospital mortality for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients of all ages has declined...
Decrease Seen in Suicide Rate in the United States
FRIDAY, April 9, 2021 -- There was a nearly 6 percent drop in suicides in the United States last year, the largest annual decline in close to four decades,...
Supply of J&J COVID-19 Vaccine to Drop 86 Percent Next Week
FRIDAY, April 9, 2021 -- In a setback to a national vaccination campaign that was finally gaining ground, the federal government said Thursday that Johnson...
First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced
FRIDAY, April 9, 2021 -- The world's first transplant of lung tissue from living donors to a COVID-19 patient with severe lung damage was announced Thursday by...
Scientists Find Clues to Why AstraZeneca's Vaccine May Cause Clots
FRIDAY, April 9, 2021 -- Doctors might have figured out why AstraZeneca's COVID-19 vaccine may cause life-threatening blood clots in very rare cases. The...
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
NEW YORK--(BUSINESS WIRE) April 07, 2021 -- Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority...
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD
ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with carfilzomib and...
FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia
Morristown, N.J. March 31, 2021 -- Althera Pharmaceuticals, a company focused on heart health, today announced the FDA approval of Roszet (rosuvastatin and...
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
DUBLIN, March 30, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a...
Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
CAMBRIDGE, Mass., March 30, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives...
U.S. FDA Accepts AbbVie's New Drug Application for Atogepant for the Preventive Treatment of Migraine
NORTH CHICAGO, Ill., March 30, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New...
Mirum Pharmaceuticals Announces FDA Acceptance of New Drug Application and Priority Review for Maralixibat in Alagille Syndrome
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mar. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced today that its New Drug Application (NDA) for...
TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in Combination with Ukoniq (umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the completion of the rolling submission of a Biologics...
FDA Approves New Indication & New Product Formulation for Myrbetriq for Use in Children with Neurogenic Detrusor Overactivity (NDO)
TOKYO, March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food...
NIH Begins Study of Allergic Reactions to Moderna, Pfizer-BioNTech COVID-19 Vaccines
April 7, 2021 -- A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an...
Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 7, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...
Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing
New Brunswick, NJ (April 3, 2021) – Johnson & Johnson is assuming full responsibility regarding the manufacturing of drug substance for its COVID-19...
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
Thursday, April 01, 2021 Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy...
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
March 31, 2021 In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of...
Browse by News Type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.